Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) announced that CEO Sharon Mates, Ph.D., will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022, at 8:40 am ET. Attendees can access the live and archived webcast through the Investor Relations section of the company's website. Intra-Cellular Therapies focuses on innovative treatments for central nervous system disorders, leveraging Nobel prize-winning research to understand cellular impacts of therapies. For more details, visit www.intracellulartherapies.com.

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 8:40 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

FAQ

When is Sharon Mates presenting at the SVB Leerink Global Healthcare Conference for ITCI?

Sharon Mates is scheduled to present on February 17, 2022, at 8:40 am ET.

How can I access the live webcast of the ITCI conference presentation?

The live and archived webcast can be accessed under the 'Events & Presentations' section of Intra-Cellular Therapies' website.

What is the focus area of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

What is the ticker symbol for Intra-Cellular Therapies?

The ticker symbol for Intra-Cellular Therapies is ITCI.

What type of company is Intra-Cellular Therapies?

Intra-Cellular Therapies is a biopharmaceutical company that develops treatments for complex psychiatric and neurologic diseases.